Preventing myringotomy closure with topical mitomycin C in rats

Area of Science:

• Otolaryngology
• Surgical Research
• Biomedical Engineering

Background:

• Myringotomy, an incision in the tympanic membrane, is often managed with ventilation tubes.
• Prolonging myringotomy site patency without tubes could offer an alternative management strategy.
• Mitomycin C is an antifibrotic agent with potential applications in preventing tissue closure.

Purpose of the Study:

• To investigate the efficacy of mitomycin C in maintaining the patency of myringotomy sites in rats.
• To evaluate the impact of varied mitomycin C exposure durations and repeat applications on patency.
• To assess mitomycin C as a potential alternative to ventilation tubes for myringotomy management.

Main Methods:

• Sixty rats underwent myringotomy, with experimental ears treated with mitomycin C and control ears with saline.
• Four treatment groups received single or repeat applications of mitomycin C at varying durations (10 or 20 minutes).
• Patency of the myringotomy sites was monitored, and healing times were compared between groups.

Main Results:

• Mitomycin C significantly prolonged myringotomy site patency compared to controls (median 5.5–8.5 weeks vs. 1.5 weeks).
• The control tympanic membranes healed within 1.5 weeks.
• Statistical significance (P < 0.001) was observed for all mitomycin C treatment groups compared to controls.

Conclusions:

• Mitomycin C demonstrates effectiveness in prolonging the patency of myringotomy sites in rat tympanic membranes.
• Neither increased exposure time nor repeat application of mitomycin C significantly altered the patency duration.
• These findings suggest mitomycin C as a viable option for maintaining myringotomy site patency.